CCM Research Issues Technical Research Report on Biorem Inc.
CCM Research has written a Technical Research Report on Biorem Inc.
Toronto, Ontario CANADA, March 02, 2009 /FSC/ - Biorem Inc. (BRM - TSX Venture), manufactures Biosorbens(r) biofilter media and is a leading supplier of biofilters and biotrickling for air pollution control in municipal and industrial applications, including BIOCUBE(r) modular units and Mytilus(r) biotrickling filters. With over 600 installed systems and over a decade of experience, the Company's products are the technology of choice for odor control at wastewater treatment plants across North America. Additional information on BIOREM(r) is also available at www.biorem.biz.
Technical Reports are designed for those investors who consult technical analysis for their investing/trading decisions. Technical investors account for a large percentage of total investors, especially in the small cap market. This type of analytical data gives investors an idea of market psychology regarding the stock by way of moving averages vis-a-vis stock price and sentiment. It provides investors with relevant price points for their buy/sell decisions - resist/support. Technical Reports also state whether or not a company is a value, neutral, or momentum investment - based on the level of overbuying or overselling.
The Technical Report on Biorem explains the following:
"BRM is currently trading at an all time low of $0.44. Overhead resistance remains at $1.00. BRM is extremely OVERSOLD and it is our opinion that the selling pressure that the stock has experienced is entirely due to broad market conditions and sentiment."
"Based on this, we feel that BRM remains an extremely attractive VALUE stock. As sentiment improves and the broad market stabilizes, we feel that BRM will return to its recent trading range of $1.00 to $1.50."
A free copy of the report can be found at:
http://www.baystreet.ca/articles/research_reports/ccm_research/BRM_TechnicalReport_Mar_2%202009.pdf
CCM Research is a division of Cronus Capital Markets, Inc. Cronus Capital Markets, Inc., through its CCM Corporate Advisory division, entered into a one year C$55,000.00 contract with the Company to assist it with the creation and execution of information-based strategies to overcome market inefficiencies that are commonplace for the vast majority of public companies, including: share illiquidity, lack of credibility, and stagnant market capitalization.
Cronus Capital Markets(r) (CCM) is a leading capital market services firm providing services to investors, institutions, exchanges, and public companies. CCM's equity research, indexes, and ETFs receive international attention and represent important new sectors of growth.
The TSX Venture Exchange has neither approved nor disapproved the contents of the press release.
SOURCE: Cronus Capital Markets
Peter Soni
Director of Research
T: 416-368-3700 ext 225
E: Peter@cronuscapitalmarkets.com
CRONUS CAPITAL MARKETS, INC. IS THE SOLE SOURCE OF THIS PRESS RELEASE
Maximum News Dissemination by Filing Services Canada Inc. *
www.usetdas.com